Novocure terminates LUNAR-4 lung cancer trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. TSLA
2. SPY
3. META
4. INTC
5. HOOD
6. STZ
7. FUTU
8. AMZN
9. MSFT
10. SPCX

Go back to Novocure terminates LUNAR-4 lung cancer trial
(NASDAQ: NVCR) Delayed: 17.20 +1.42 (9.00%)
Previous Close $15.78    52 Week High $28.95 
Open $15.87    52 Week Low $5.95 
Day High $17.31    P/E N/A 
Day Low $15.61    EPS $0.00 
Volume 1,953,474